79 related articles for article (PubMed ID: 24939856)
1. The role of S100A14 in epithelial ovarian tumors.
Cho H; Shin HY; Kim S; Kim JS; Chung JY; Chung EJ; Chun KH; Hewitt SM; Kim JH
Oncotarget; 2014 Jun; 5(11):3482-96. PubMed ID: 24939856
[TBL] [Abstract][Full Text] [Related]
2. Transcription factor ZIC2 regulates the tumorigenic phenotypes associated with both bulk and cancer stem cells in epithelial ovarian cancer.
Chen H; Lee LJ; Vincent KM; Xu Z; Liu J; Zhang G; Nakevska Z; Smith D; Lee CH; Postovit LM; Fu Y
Oncogene; 2024 May; 43(22):1688-1700. PubMed ID: 38594503
[TBL] [Abstract][Full Text] [Related]
3. KCNN4 and S100A14 act as predictors of recurrence in optimally debulked patients with serous ovarian cancer.
Zhao H; Guo E; Hu T; Sun Q; Wu J; Lin X; Luo D; Sun C; Wang C; Zhou B; Li N; Xia M; Lu H; Meng L; Xu X; Hu J; Ma D; Chen G; Zhu T
Oncotarget; 2016 Jul; 7(28):43924-43938. PubMed ID: 27270322
[TBL] [Abstract][Full Text] [Related]
4. TMED3 stabilizes SMAD2 by counteracting NEDD4-mediated ubiquitination to promote ovarian cancer.
Chen X; Zhang W; Han X; Li X; Xia L; Wu Y; Zhou Y
Mol Carcinog; 2024 May; 63(5):803-816. PubMed ID: 38411267
[TBL] [Abstract][Full Text] [Related]
5. Sphingolipid metabolites modulate dielectric characteristics of cells in a mouse ovarian cancer progression model.
Salmanzadeh A; Elvington ES; Roberts PC; Schmelz EM; Davalos RV
Integr Biol (Camb); 2013 Jun; 5(6):843-52. PubMed ID: 23609351
[TBL] [Abstract][Full Text] [Related]
6. Epithelial cancers in the post-genomic era: should we reconsider our lifestyle?
Holly JM; Zeng L; Perks CM
Cancer Metastasis Rev; 2013 Dec; 32(3-4):673-705. PubMed ID: 23907184
[TBL] [Abstract][Full Text] [Related]
7. S100A14, a mediator of epithelial-mesenchymal transition, regulates proliferation, migration and invasion of human cervical cancer cells.
Wang X; Yang J; Qian J; Liu Z; Chen H; Cui Z
Am J Cancer Res; 2015; 5(4):1484-95. PubMed ID: 26101712
[TBL] [Abstract][Full Text] [Related]
8. Co-expression of S100A14 and S100A16 correlates with a poor prognosis in human breast cancer and promotes cancer cell invasion.
Tanaka M; Ichikawa-Tomikawa N; Shishito N; Nishiura K; Miura T; Hozumi A; Chiba H; Yoshida S; Ohtake T; Sugino T
BMC Cancer; 2015 Feb; 15():53. PubMed ID: 25884418
[TBL] [Abstract][Full Text] [Related]
9. New serum tumor markers S100, TFF3 and AIF-1 and their possible use in oncogynecology.
Maděrka M; Pilka R; Neubert D; Hambálek J
Ceska Gynekol; 2019; 84(4):303-308. PubMed ID: 31818115
[TBL] [Abstract][Full Text] [Related]
10. Integrative analysis of gene expression and DNA methylation to identify biomarkers of non-genital warts induced by low-risk human papillomaviruses infection.
Alghamdi MA; Al-Eitan LN; Tarkhan AH
Heliyon; 2023 May; 9(5):e16101. PubMed ID: 37215908
[TBL] [Abstract][Full Text] [Related]
11. Significance of a calcium-binding protein S100A14 expression in colon cancer progression.
Hashida H; Coffey RJ
J Gastrointest Oncol; 2022 Feb; 13(1):149-162. PubMed ID: 35284114
[TBL] [Abstract][Full Text] [Related]
12. A machine learning approach to identify predictive molecular markers for cisplatin chemosensitivity following surgical resection in ovarian cancer.
Shannon NB; Tan LLY; Tan QX; Tan JW; Hendrikson J; Ng WH; Ng G; Liu Y; Ong XS; Nadarajah R; Wong JSM; Tan GHC; Soo KC; Teo MCC; Chia CS; Ong CJ
Sci Rep; 2021 Aug; 11(1):16829. PubMed ID: 34413360
[TBL] [Abstract][Full Text] [Related]
13. S100 family members: potential therapeutic target in patients with hepatocellular carcinoma: A STROBE study.
Zhang C; Yao R; Chen J; Zou Q; Zeng L
Medicine (Baltimore); 2021 Jan; 100(3):e24135. PubMed ID: 33546025
[TBL] [Abstract][Full Text] [Related]
14. Tetraspanin 1 promotes endometriosis leading to ovarian clear cell carcinoma.
Shin HY; Yang W; Chay DB; Lee EJ; Chung JY; Kim HS; Kim JH
Mol Oncol; 2021 Apr; 15(4):987-1004. PubMed ID: 33331115
[TBL] [Abstract][Full Text] [Related]
15. A Clinicopathological Analysis of S100A14 Expression in Colorectal Cancer.
Diamantopoulou A; Mantas D; Kostakis ID; Agrogiannis G; Garoufalia Z; Kavantzas N; Kouraklis G
In Vivo; 2020; 34(1):321-330. PubMed ID: 31882495
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and clinicopathological significance of S100A14 expression in cancer patients: A meta-analysis.
Hu L; Kong F; Pan Y
Medicine (Baltimore); 2019 Jul; 98(28):e16356. PubMed ID: 31305429
[TBL] [Abstract][Full Text] [Related]
17. Identification of S100A14 as a metastasis-promoting molecule in a murine organotropic metastasis model.
Sugino T; Ichikawa-Tomikawa N; Tanaka M; Shishito N; Miura T; Abe M; Muramatsu K; Oishi T; Kakuda Y; Kawata T; Akiyama Y
Clin Exp Metastasis; 2019 Aug; 36(4):411-422. PubMed ID: 31263990
[TBL] [Abstract][Full Text] [Related]
18. Expression profile and functional role of S100A14 in human cancer.
Basnet S; Sharma S; Costea DE; Sapkota D
Oncotarget; 2019 Apr; 10(31):2996-3012. PubMed ID: 31105881
[TBL] [Abstract][Full Text] [Related]
19. Prognostic values of S100 family members in ovarian cancer patients.
Bai Y; Li LD; Li J; Lu X
BMC Cancer; 2018 Dec; 18(1):1256. PubMed ID: 30558666
[TBL] [Abstract][Full Text] [Related]
20. S100A14 Is Increased in Activated NK Cells and Plasma of HIV-Exposed Seronegative People Who Inject Drugs and Promotes Monocyte-NK Crosstalk.
Colón K; Speicher DW; Smith P; Taylor M; Metzger DS; Montaner LJ; Tomescu C
J Acquir Immune Defic Syndr; 2019 Feb; 80(2):234-241. PubMed ID: 30422902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
